林素卿。開發核酸穿透式運輸系統。國立成功大學生物科技研究所碩士論文，1-57。(2003)。
黃馨怡。穿透性蛋白的功能和特性分析。國立成功大學生物科技研究所碩士論文，1-24。(2005)。
Alsner J., Svejstrup J.Q., Kjeldsen E., Sorensen B.S., and Westergaard O. Identifcation of an N-terminal domain of eukaryotic DNA topoisomerase I dispensable for catalytic activity but essential for in vivo function. J. Biol. Chem. 267, 12408–12411. (1992)
Alan Ho, Steven R. Sachwarze, Sarah J. Mermelstein, Gabriel Waksman, and Steven F. Dowdy.
Synthetic Protein Transduction Domains: Enhanced Transduction Potential in Vitro and in Vivo.
CANCER RESEARCH 61, 474-477. (2001)
Becker-Hapak M., McAllister S.S. and Dowdy S.F. TAT-mediated protein transduction into mammalian cells. Methods 24, 247-256. (2001)
Baca-Estrada M. E., Foldvari M., Babiuk S. L. and Babiuk L. A. Vaccine delivery: lipid-based delivery systems. J. Biotechnol. 83, 91-104. (2000)
Barry M.A. and Johnston S.A. Biological features of genetic immunization. Vaccine 15, 788-791.
(1997)
Birnboim H.C. and Doly J. (1979) A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 7, 1513-1523.
Bharti A.K., Olson M.O., Kufe D.W., and Rubin E.H. Identifcation of a nucleolin binding site in human topoisomerase I. J. Biol. Chem. 271, 1993-1997. (1996)
Blin N., and Stafford D.W. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res. 3, 2303-2308. (1976)
Chen T.Y., Hsu C.T., Chang K.H., Ting C.Y., Whang-Peng J., Hui C.F., and Hwang J. Development of DNA delivery system using Pseudomonas exotoxin A and a DNA binding region of human DNA topoisomerase I. Appl. Microbiol. Biotechnol. 53, 558-567. (2000)
Chia-Tse Hsu, Chun-Yuan Ting, Mei-Luen Yang, Tzong-Yuen Chen, and Jaulang Hwang Characterization and application of human DNA topoisomerase I nickel binding motif.(2006) D’arpa P., Machlin P.S., III H.R., Rothfield N.F., Cleveland D.W., and Earnshaw W.C. cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment. Proc. Natl. Acad. Sci. USA 85, 2543-2547. (1988)
N.M. Dean, R. McKay, T.P. Condon & C.F. Bennett. Inhibition of protein kinase C-expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1(lCAM-1)mRNA by phorbol esters. J. Biol. Chem. 269, 16416-16424. (1994)
Edwards T.K., Saleem A., Shaman J.A., Dennis T., Gerigk C., Oliveros E., Gartenberg M.R., and Rubin E. H. Role for nucleolin/Nsr1 in the cellular localization of topoisomerase I. J. Biol. Chem.
275, 36181-36188. (2000)
Ehsan, A., Mann, M.J., Dell’Acqua, G. & Dzau, V.J. Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy
oligonucleotide gene therapy. J. Thorac. Cardiovasc. Surg. 121, 714-722. (2001)
Elliott G., and O’Hare P. Intercellular trafficking and protein delivery by a herpes virus structural protein. Cell 88, 223-233. (1997)
Evelyn T. P. (A historical review of fish vaccinology. Dev. Biol. Stand. 90, 3-12. 1997)
Feltquate D.M. DNA vaccines: vector design, delivery, and antigen presentation. J. Cell. Biochem.
Suppl. 30/31, 304-311. (1998)
Ford K. G., Souberbielle B. E., Darling D., and Farzaneh F. Protein transduction: an alternative to genetic intervention? Gene Therapy. 8, 1-4. (2001)
Fawell, S., Seery J., Daikh Y., Moore C., Chen L. L., Pepinsky B., and Barsoum J. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA. 91, 664-668. (1994)
Falnes P. O., Wesche J., and Olsnes S. Ability of the Tat basic domain and VP22 to mediate cell binding, but not membrane translocation of the diphtheria toxin A-fragment. Biochemistry 40, 4349-4358. (2001)
Gudding R., Lillehaug A., and Evensen O. Recent developments in fish vaccinology. Vet. Immunol.
Immunopathol. 72, 203-212. (1999)
Gorman C. M., Moffat L. F., and Howard B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2, 1044-1051. (1982)
Heppell J., and Davis H. L. Application of DNA vaccine technology to aquaculture. Adv. Drug Deliv. Rev. 43, 29–43. (2000)
Joanna B. Opalinska and M. Gewirtz. NUCLEIC-ACID THERAPEUTICS: BASIC PRINCIPLES AND RECENT APPLICATIONS. NATURE REVIEWS│DRUG DOSCOVERY 1, 503-514. (2002) J. Gariépy and K. Kawnmura. Vectorial delivery of macromolecules into cells using peptide-based vehicles. Trends in Biotechnology 19, 21-28. (2001)
J.L. Macpherson,, J.A. Ely Sun, L.Q. & G.P. Symonds. Ribozymes in gene therapy of HIV-1. Front.
Biosci. 4, D497-D505. (1999)
Kanellos T., Sylvester I. D., Howard C. R., and Russell P. H. DNA is as effective as protein at inducing antibody in fish. Vaccine 17, 965-972. (1999)
Koide Y., Nagata T., Yoshida A., and Uchijima M. DNA vaccines. Jpn. J. Pharmacol. 83, 167-174.
(2000)
Lai Z., Han I., Zirzow G., Brady R. O., and Reiser J. Intercellular delivery of a herpes simplex virus VP22 fusion protein from cells infected with lentiviral vectors. Proc. Natl. Acad. Sci. USA 97, 11297-11302. (2000)
Martin L. Read*, Surjeet Singh1, Zubair Ahmed, Mark Stevenson2, Simon S. Briggs2,David Oupicky3, Lee B. Barrett4, Rachel Spice, Mark Kendall5, Martin Berry,Jon A. Preece1, Ann Logan and Leonard W. Seymour . A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids. N u c l e i c A c i d s R e s e a r c h , Vol. 33, No. 9(2005) M.J. mann., et al. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the
PREVENT single centre, randomized, controlled trial. Lancet 354, 1493-1498. (1999)
Morris M.C., Depollier J., Mery J., Heitz F., and Divita G. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol. 19, 1173-1176. (2001)
Morris M.C., Chaloin L., Choob M., Archdeacon J., Heitz F and G Divita. Combination of a new generation of PNAs with a peptide-based carrier enables efficient targeting of cell cycle progression.
Gene Therapy. 1-8. (2004)
Montgomery D.L., Ulmer J.B., Donnelly J.J., and Liu M.A. DNA vaccines. Pharmacol. Ther. 74, 195-205. (1997)
Mao Y., Mehl I.R., and Muller M.T. Subnuclear distribution of topoisomerase I is linked to ongoing transcription and p53 status Proc. Natl. Acad. Sci. USA 99, 1235-1240. (2002)
Mo Y.Y., Wang C., and Beck W.T. A novel nuclear localization signal in human DNA topoisomerase I. J. Biol. Chem. 275, 41107-41113. (2000)
Morris M.C., Vidal, P., Chaloin, L., Heitz F., and Divita G. A new peptide vector for efficient delivery of oligonucleotide into nontransformed mammalian cells. Nucleic Acids Res. 25, 2730-2736. (2001)
Mitani K., and Caskey C.T. Delivering therapeutic genes-matching approach and application.
Trends in Biotechnology. 11: 5. 162-166. (1993)
Normand N., Leeuwen H., and O’Hare P. Particle formation by a conserved domain of the herpes simplex virus protein VP22 facilitating protein and nucleic acid delivery. J. Biol. Chem. 276, 15042-15050. (2001)
Niidome T., and Huang L. Gene therapy progress and prospects: nonviral vectors. Gene Ther. 9, 16471652. (2002)
Nagasaki T., Myohoji T., Tachibana T., Futaki S., and Tamagaki S. Can nuclear localization signals enhance nuclear localization of plasmid DNA? Bioconjugate Chem. 14, 282-286(2003)
Oliveira S.C., Rosinha G.M., de-Brito C.F., Fonseca C.T., Afonso R. R., Costa M.C., Goes A.M., Rech E.L., and Azevedo V. Immunological properties of gene vaccines delivered by different routes.
Braz. J. Med. Biol. Res. 32, 207-214. (1999)
Phelan A., Elliott G., and O’Hare P. Intercellolar delivery of functional p53 by the herpes virus protein VP22. Nat. Biotechnol. 16, 440-443. (1998)
Pachuk C.J., McCallus D.E., Weiner D.B., and Satishchandran C. DNA vaccines--challenges in delivery. Curr. Opin. Mol. Ther. 2, 188-198. (2000)
Shedlock D.J., and Weiner D.B. DNA vaccination : antigen presentation and the induction of immunity. J. Leukoc. Biol. 68, 793-806. (2000)
Schneider H., Huse K., Birkenmieier G., Otto A., and Scholz G.H. Gene transfer mediated by α2-macroglobulin. Nucleic Acids Res. 24, 3873-3874. (1996)
Southern E.M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98, 503-517. (1975)
Schwarze S.R., Ho A., Vocero-Akbani A., and Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into mouse. Science 285, 1569-1572. (1999)
Schwartz J.J., and Zhang S. Peptide-mediated cellular delivery. Curr. Opin. Mol. Ther. 2, 162-7.
(2000)
Scheerlinck J. Y. Genetic adjuvants for DNA vaccines. Vaccine 19, 2647–2656. (2001)
S.R. Schwarze, K.A. Hruska and S.F. Dowdy. Protein transduction: Unrestricted delivery into all cells? Trends Cell Biol. 10, 209-295. (2000)
Tang D., DeVit M., and Johnston S. A. Genetic immunization is a simple method for eliciting an immune response. Nature 365, 152-154. (1992)
Tuteja R. DNA vaccines: a ray of hope. Crit. Rev. Biochem. Mol. Biol. 34, 1-24. (1999)
Vives, E., Brodin, P., and Lebleu, B.A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272, 16010-16017. (1997)
van Drunen Littel-van den Hurk S., Gerdts V., Loehr B.I., Pontarollo R., Rankin R., Uwiera R., and Babiuk L.A. Recent advances in the use of DNA vaccines for the treatment of diseases of farmed animals. Adv. Drug. Deliv. Rev. 43, 13-28. (2000)
Whitton, J.L. et al. A "string-of-beads" vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge. J. Virol. 67, 348-352. (1993)
Whitton J.L., Rodriguez F., Zhang J., and Hassett D.E. DNA immunization: mechanistic studies.
Vaccine 17, 1612-1619. (1999)
Wilson J. M., Grossman M., Wu C. H., Chowdhury N. R., and Wu G. Y. Hepatocyte-directed gene transfer in vivo leads to transient improvement of hypercholesterolemia in low density lipoprotein receptor-deficient rabbits. J. Biol. Chem. 267, 963-967. (1992.a)
Wilson J. M., Grossman M., Carbrera J., Wu C. H., and Wu G. Y. A novel mechanism for achieving transgene persistence in vivo after gene transfer into hepatocytes. J. Biol. Chem. 267, 11483-11489. (1992.b)
Wolff, J.A. and Lederberg, J. Human Gene Therapy: 5, 469. (1994)
Zanta M. A., Belguise-Valladier P., and Behr J. P. Gene delivery: A single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc. Natl. Acad. Sci. USA 96, 91-96.
(1999)
Zhu N., Liggit D., Liu Y., and Debs R. Systemic gene expression after intravenous DNA delivery into adult mice. Science 261, 209-211. (1993)